{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:57:05Z","timestamp":1782842225922,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.xphs.2020.09.045","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T10:34:48Z","timestamp":1603535688000},"page":"898-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of In\u00a0Vivo Transportability of Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents Into Intracellular and Extracellular Tissue Spaces in Rats"],"prefix":"10.1016","volume":"110","author":[{"given":"Shinji","family":"Kobuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Sakaeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2020.09.045_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1039\/C9MD00044E","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype","volume":"10","author":"Craft","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.xphs.2020.09.045_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.xphs.2020.09.045_bib3","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2106\/00004623-200506000-00022","article-title":"Internalization of bacteria by osteoblasts in a patient with recurrent, long-term osteomyelitis. A case report","volume":"87","author":"Bosse","year":"2005","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.xphs.2020.09.045_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/432735","article-title":"Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis","volume":"192","author":"Clement","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.xphs.2020.09.045_bib5","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1462-5822.2008.01166.x","article-title":"The expression of \u03b1-haemolysin is required for Staphylococcus aureus phagosomal escape after internalization in CFT-1 cells","volume":"10","author":"Jarry","year":"2008","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.xphs.2020.09.045_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature16057","article-title":"Novel antibody-antibiotic conjugate eliminates intracellular S. aureus","volume":"527","author":"Lehar","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xphs.2020.09.045_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02588-18","article-title":"A\u00a0phase 1, randomized, single-ascending-dose study to investigate the safety, tolerability, and pharmacokinetics of DSTA4637S, an anti-Staphylococcus aureus thiomab antibody-antibiotic conjugate, in healthy volunteers","volume":"63","author":"Peck","year":"2019","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib8","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/AAC.01605-07","article-title":"Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model","volume":"53","author":"Sandberg","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jiac.2016.02.012","article-title":"Empirical therapy in Methicillin-resistant Staphylococcus Aureus infections: an Up-To-Date approach","volume":"22","author":"VanEperen","year":"2016","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/BF01967563","article-title":"Structure, biochemistry and mechanism of action of glycopeptide antibiotics","volume":"8","author":"Reynolds","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.xphs.2020.09.045_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.mi.38.100184.002011","article-title":"The structure and mode of action of glycopeptide antibiotics of the vancomycin group","volume":"38","author":"Barna","year":"1984","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.xphs.2020.09.045_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1074-5521(96)90079-4","article-title":"Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story","volume":"3","author":"Walsh","year":"1996","journal-title":"Chem Biol"},{"issue":"5","key":"10.1016\/j.xphs.2020.09.045_bib13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/AAC.24.5.797","article-title":"Mechanism of action of habekacin, a novel amino acid-containing aminoglycoside antibiotic","volume":"24","author":"Tanaka","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib14","first-page":"23","article-title":"Linezolid\u2013a new option for treating gram-positive infections","volume":"14","author":"Batts","year":"2000","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.xphs.2020.09.045_bib15","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","article-title":"Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus","volume":"47","author":"Silverman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/AAC.50.3.841-851.2006","article-title":"Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages","volume":"50","author":"Barcia-Macay","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7150\/ijms.13601","article-title":"Therapeutic drug monitoring of vancomycin in dermal interstitial fluid using dissolving microneedles","volume":"13","author":"Ito","year":"2016","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.xphs.2020.09.045_bib18","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1128\/AAC.01570-16","article-title":"Transport of azithromycin into extravascular space in rats","volume":"60","author":"Kobuchi","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/antibiotics9040199","article-title":"Pharmacokinetics of macrolide antibiotics and transport into the interstitial fluid: comparison among erythromycin, clarithromycin, and azithromycin","volume":"9","author":"Kobuchi","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.xphs.2020.09.045_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jiac.2013.08.008","volume":"20","author":"Okada","year":"2014","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/2047-783X-15-12-533","article-title":"Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin","volume":"15","author":"Estes","year":"2010","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.xphs.2020.09.045_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1570-0232(03)00068-0","article-title":"Highly sensitive quantification of vancomycin in plasma samples using liquid chromatography-tandem mass spectrometry and oral bioavailability in rats","volume":"789","author":"Shibata","year":"2003","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.xphs.2020.09.045_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cca.2013.01.004","article-title":"Rapid quantification of the aminoglycoside arbekacin in serum using high performance liquid chromatography-tandem mass spectrometry","volume":"418","author":"Breaud","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.xphs.2020.09.045_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpba.2012.04.007","article-title":"Rapid and sensitive LC-MS\/MS method for the analysis of antibiotic linezolid on dried blood spot","volume":"67\u201368","author":"la Marca","year":"2012","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2020.09.045_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpba.2019.02.037","article-title":"LC-MS\/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples","volume":"169","author":"Ferrari","year":"2019","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2020.09.045_bib26","doi-asserted-by":"crossref","first-page":"113273","DOI":"10.1016\/j.jpba.2020.113273","article-title":"A\u00a0liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: application to critically ill pediatric patients","volume":"186","author":"Barco","year":"2020","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2020.09.045_bib27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s40064-015-1228-8","article-title":"Enhanced oral bioavailability of vancomycin in rats treated with long-term parenteral nutrition","volume":"4","author":"Fukushima","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.xphs.2020.09.045_bib28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejcts.2010.02.002","article-title":"Vancomycin lung concentration in acute and hyperacute rejection models of lung transplantation in rats","volume":"38","author":"Pier\u00f3g","year":"2010","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.xphs.2020.09.045_bib29","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/AAC.20.6.718","article-title":"Comparison of vancomycin disposition in rats with normal and abnormal renal functions","volume":"20","author":"Engineer","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib30","first-page":"357","article-title":"Absorption, distribution, and excretion of arbekacin after intravenous and intramuscular administration in rats","volume":"40","author":"Mitomi","year":"1987","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.xphs.2020.09.045_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40780-018-0123-1","article-title":"Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies","volume":"4","author":"Hashimoto","year":"2018","journal-title":"J\u00a0Pharm Health Care Sci"},{"key":"10.1016\/j.xphs.2020.09.045_bib32","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/00498250210158249","article-title":"Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog","volume":"32","author":"Slatter","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2020.09.045_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1248\/bpb.26.573","article-title":"Assessment of radioactive residues arising from radiolabel instability in a multiple dose tissue distribution study in rats","volume":"26","author":"Slatter","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.xphs.2020.09.045_bib34","first-page":"79","article-title":"Pharmacokinetics and skin-tissue penetration of daptomycin in rats","volume":"7","author":"Matsumoto","year":"2015","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.xphs.2020.09.045_bib35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/jac\/25.4.635","article-title":"Experimental studies on nephrotoxicity and pharmacokinetics of LY 146032 (daptomycin) in rats","volume":"25","author":"Kreft","year":"1990","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib36","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1128\/AAC.00589-08","article-title":"In\u00a0vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib37","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.47.4.1318-1323.2003","article-title":"Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects","volume":"47","author":"Dvorchik","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/tcrm.2006.2.4.455","article-title":"Update on the appropriate use of linezolid in clinical practice","volume":"2","author":"Manfredi","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.xphs.2020.09.045_bib39","first-page":"1067","article-title":"Linezolid concentrations in plasma and subcutaneous tissue are reduced in obese patients, resulting in a higher risk of underdosing in critically ill patients: a controlled clinical pharmacokinetic study","volume":"9","author":"Simon","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.xphs.2020.09.045_bib40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/jac\/39.4.471","article-title":"Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus","volume":"39","author":"Watanabe","year":"1997","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib41","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1002\/jps.23309","article-title":"Therapeutic drug monitoring in interstitial fluid: a feasibility study using a comprehensive panel of drugs","volume":"101","author":"Kiang","year":"2012","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2020.09.045_bib42","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/jac\/dkv074","article-title":"Vancomycin serum concentrations do not adequately predict tissue exposure in diabetic patients with mild to moderate limb infections","volume":"70","author":"Hamada","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijantimicag.2018.09.021","article-title":"Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis","volume":"53","author":"Abraham","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.xphs.2020.09.045_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17460441003605098","article-title":"Lipophilicity in drug discovery","volume":"5","author":"Waring","year":"2010","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.xphs.2020.09.045_bib45","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1023\/A:1015040217741","article-title":"Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs","volume":"16","author":"Kelder","year":"1999","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2020.09.045_bib46","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1086\/430352","article-title":"Inhibition of daptomycin by pulmonary surfactant: in\u00a0vitro modeling and clinical impact","volume":"191","author":"Silverman","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.xphs.2020.09.045_bib47","first-page":"44","article-title":"Attenuation of arbekacin-induced nephrotoxicity in rats by pazufloxacin mesylate","volume":"56","author":"Kizawa","year":"2003","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.xphs.2020.09.045_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0714.1987.tb00674.x","article-title":"Evaluation of pH changes in inflammation of the subcutaneous air pouch lining in the rat, induced by carrageenan, dextran and Staphylococcus aureus","volume":"16","author":"Punnia-Moorthy","year":"1987","journal-title":"J\u00a0Oral Pathol"},{"key":"10.1016\/j.xphs.2020.09.045_bib49","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1128\/AAC.38.10.2449","article-title":"Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid [published correction appears in Antimicrob Agents Chemother 1995 Mar;39(3):795]","volume":"38","author":"Freeman","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2020.09.045_bib50","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijantimicag.2010.01.023","article-title":"Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic\/pharmacodynamic indices","volume":"35","author":"Barbour","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.xphs.2020.09.045_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","article-title":"The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents","volume":"77","author":"Blot","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2020.09.045_bib52","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/00498254.2019.1654633","article-title":"Pharmacokinetics and lung distribution of macrolide antibiotics in sepsis model rats","volume":"50","author":"Kobuchi","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2020.09.045_bib53","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/hep.20387","article-title":"Interleukin 1 beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance","volume":"40","author":"Assenat","year":"2004","journal-title":"Hepatology"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920305761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920305761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:32:26Z","timestamp":1758360746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920305761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0022354920305761"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.045","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of In\u00a0Vivo Transportability of Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents Into Intracellular and Extracellular Tissue Spaces in Rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}